“The clearance of NeuroRPM is a major milestone in the fight against Parkinson’s disease,” Alexander Ksendzovsky, MD, PhD, cofounder and chief scientific officer of NeuroRPM, the app’s developer, said in a company press release."
"The app runs on the Apple Watch and offers an easy and effective way to continuously monitor symptoms and other health metrics important for Parkinson’s disease, the company reported. Among symptoms captured by the wrist-worn device are bradykinesia, or abnormally slow movements; tremor; and dyskinesia, the uncontrolled and involuntary movements that can affect patients."
-----------------
First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's 
